• Chatbot
  • Help and guidance
  • Find your DNB office
  • Make an appointment

DNB Bioteknologi

DNB Bioteknologi is an equity fund which primarily invests in shares listed on stock exchanges and regulated markets across the world.

Woman researching in a laboratory
  • Actively managed equity fund

  • Invests in vaccines, medicines and diagnostics

  • On your mobile phone, you buy DNB Biotechnology in The Spare app

You can buy DNB Bioteknologi using a computer or in the Spare app

DNB Bioteknologi

The fund mainly invests in the following sectors:

  • Biotechnology
  • Diagnostics
  • Pharmacy
  • Production of pharmaceutical products
  • Biological medicines including gene therapy
  • Other health-related businesses

Read more about DNB Bioteknologi (DNB Biotechnology)

Minimum purchase amount is NOK 100. With a savings scheme in mutual funds, your savings happen automatically every month.

Costs for DNB Biotechnology A

  • Annual cost 1.15%
  • Ongoing charge: 0,85 %
  • Platform fee : 0.30 %

Price example: For an amount of NOK 100,000 invested, the platform fee will be NOK 300 and ongoing costs will amount to NOK 850 over the course of one year. In total NOK 1150 per year.

Pricing model for mutual funds

DNB Biotechnology management team

The health funds in DNB Asset Management are managed by a team with extensive experience in medicine and finance, consisting of:

  • Benedicte Kilander Bakke
  • Rune Sand
  • Anesa Mulabecirovic Sahnoun

Benedicte is a qualified dentist in addition to being an authorised financial analyst (AFA) with an MBA in Finance, Rune has a master’s degree in Finance and also an AFA and an MBA in Finance, and Anesa is a medic with a doctorate in medicine and also has an MBA in Finance.

Historical returns are no guarantee of future returns. Future returns will depend, among other things, on market developments, the skill of the Portfolio Manager, the mutual fund’s risk, and the management costs. Returns may be negative as a result of mark-to-market losses.

Sustainability in mutual funds and in our advice

Woman sitting on a rock

SFDR is the regulation in the EU action plan for sustainable finance. SFDR ensures that financial institutions publish their financial products’ investment strategy, investment objectives and actual investments.

See more mutual funds here

Footer navigation

Head office

Dronning Eufemias gate 30

0191 Oslo, Norway

Postal address

DNB

PO Box 1600 - Sentrum

0021 Oslo

Org. no.

DNB Bank ASA

984 851 006

DNB Websites

DNB Eiendom (DNB Real Estate)#girlsinvestDNB Tech Blog

International

DNB LuxembourgDNB SwedenDNB Denmark

Social media

Terms of useData protectionCookiesPrice listCompare our prices with other companies at Finansportalen.noWork for us

© DNB